These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent. da Silva LC, Sette H, Chamone DA, Sáez-Alquezar A, Punskas JA, Raia S. Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006 [No Abstract] [Full Text] [Related]
9. [Schistosomiasis in Ceará, analysis of the current problem and suggestions for its control]. de Alencar JE, Rouquayrol MZ, de Figueiredo JS, Bezerra OF. Rev Bras Malariol Doencas Trop; 1978; 30():99-121. PubMed ID: 549156 [No Abstract] [Full Text] [Related]
10. Oxamniquine in the treatment of schistosomiasis in a population in area with low endemicity. Bina JC, Prata A. Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):94-7, 212-6. PubMed ID: 7455516 [No Abstract] [Full Text] [Related]
12. Oxamniquine (Vansil) in the treatment of Schistosoma mansoni infections in Rhodesia. de V Clarke V. Cent Afr J Med; 1977 Nov; 23(11 Suppl):20-3. PubMed ID: 606374 [No Abstract] [Full Text] [Related]